Karyopharm announces the appointment of peter k honig, md, mph to its board of directors

Newton, mass., dec. 6, 2021 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of peter k honig, md, mph, to the board of directors, effective december 3, 2021.
KPTI Ratings Summary
KPTI Quant Ranking